Cytokinetics Inc
F:KK3A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cytokinetics Inc
F:KK3A
|
US |
|
Golden Flower Tbk PT
IDX:POLU
|
ID |
|
Bluestone Jewellery and Lifestyle Ltd
NSE:BLUESTONE
|
IN |
|
Exelon Corp
NASDAQ:EXC
|
US |
|
Union Steel Holdings Ltd
SGX:ZB9
|
SG |
|
M
|
Microsoft Corp
F:MSF
|
US |
|
Safestay PLC
LSE:SSTY
|
UK |
|
China Everbright Ltd
OTC:CEVIF
|
HK |
|
L
|
LVMH Moet Hennessy Louis Vuitton SE
F:MOHF
|
FR |
|
Pensana PLC
LSE:PRE
|
UK |
|
Innospec Inc
NASDAQ:IOSP
|
US |
|
M
|
Merck & Co Inc
XHAN:6MK
|
US |
|
A
|
Atoss Software AG
XHAM:AOF
|
DE |
|
Embecta Corp
F:JX7
|
US |
|
Daiichi Life Group Inc
OTC:DCNSF
|
JP |
|
U
|
UniTest Inc
KOSDAQ:086390
|
KR |
|
Goldman Sachs Group Inc
NYSE:GS
|
US |
|
H
|
H & R Block Inc
LSE:0HOB
|
US |
|
Kaluzhskaya Sbytovaya Kompaniya PAO
MOEX:KLSB
|
RU |
|
G
|
Geiger Energy Corp
XTSX:BEEP
|
CA |
|
S
|
Sunrun Inc
F:3S9
|
US |
|
Airtificial Intelligence Structures
MAD:AI
|
ES |
|
Invex Therapeutics Ltd
ASX:IXC
|
AU |
Bankruptcy Probability
Cytokinetics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Cytokinetics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Cytokinetics Inc
NASDAQ:CYTK
|
8.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
505.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
249.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
207.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
134.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
103.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
91.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
55.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
41.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Cytokinetics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Cytokinetics Inc has total debt of 1.1B USD. This includes both short-term (0 USD) and long-term (1.1B USD) debt.
You can find a full breakdown on its Balance Sheet.
